Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 390613, 6 pages
http://dx.doi.org/10.1100/2012/390613
Research Article

Salicylic Acid Attenuates Gentamicin-Induced Nephrotoxicity in Rats

1Department of Physiology, Faculty of Medicine, University of Nis, 18000 Nis, Serbia
2Department of Pathology, Faculty of Medicine, University of Nis, 18000 Nis, Serbia
3Department of Biochemistry, Faculty of Medicine, University of Nis, 18000 Nis, Serbia
4Department of Pharmacology, Faculty of Medicine, University of Nis, 18000 Nis, Serbia

Received 27 October 2011; Accepted 22 December 2011

Academic Editor: Paolo Caraceni

Copyright © 2012 Pavle Randjelovic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Karahan, A. Ateşşahin, S. Yilmaz, A. O. Çeribaşi, and F. Sakin, “Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats,” Toxicology, vol. 215, no. 3, pp. 198–204, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Mwengee, T. Butler, S. Mgema et al., “Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania,” Clinical Infectious Diseases, vol. 42, no. 5, pp. 614–621, 2006. View at Google Scholar · View at Scopus
  3. W. E. Siegenthaler, A. Bonetti, and R. Luthy, “Aminoglycoside antibiotics in infectious diseases. An overview,” American Journal of Medicine, vol. 80, no. 6, pp. 2–14, 1986. View at Google Scholar · View at Scopus
  4. T. H. Mathew, “Drug-induced renal disease,” Medical Journal of Australia, vol. 156, no. 10, pp. 724–728, 1992. View at Google Scholar · View at Scopus
  5. A. A. Banday, N. Farooq, S. Priyamvada, A. N. K. Yusufi, and F. Khan, “Time dependent effects of gentamicin on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in rat kidney tissues,” Life Sciences, vol. 82, no. 9-10, pp. 450–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Baliga, Z. Zhang, M. Baliga, N. Ueda, and S. V. Shah, “In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity,” Kidney International, vol. 53, no. 2, pp. 394–401, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Parlakpinar, S. Tasdemir, A. Polat et al., “Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats,” Toxicology, vol. 207, no. 2, pp. 169–177, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Stojiljkovic, M. Stoiljkovic, P. Randjelovic, S. Veljkovic, and D. Mihailovic, “Cytoprotective effect of vitamin C against gentamicin-induced acute kidney injury in rats,” Experimental and Toxicologic Pathology, vol. 64, no. 1-2, pp. 69–74, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. B. H. Ali, “Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research,” Food and Chemical Toxicology, vol. 41, no. 11, pp. 1447–1452, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Dempsey and D. F. Klessig, “Salicylic acid, active oxygen species and systemic acquired resistance in plants,” Trends in Cell Biology, vol. 4, no. 9, pp. 334–338, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Dangl, “Plants just say NO to pathogens,” Nature, vol. 394, no. 6693, pp. 525–527, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Guerrero, J. A. González-Correa, M. M. Arrebola, J. Muñoz-Marín, F. Sánchez De La Cuesta, and J. P. De La Cruz, “Antioxidant effects of a single dose of acetylsalicylic acid and salicylic acid in rat brain slices subjected to oxygen-glucose deprivation in relation with its antiplatelet effect,” Neuroscience Letters, vol. 358, no. 3, pp. 153–156, 2004. View at Publisher · View at Google Scholar
  13. R. J. Dinis-Oliveira, C. Sousa, F. Remião et al., “Full survival of paraquat-exposed rats after treatment with sodium salicylate,” Free Radical Biology and Medicine, vol. 42, no. 7, pp. 1017–1028, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. O. I. Aruoma and B. Halliwell, “The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs,” Xenobiotica, vol. 18, no. 4, pp. 459–470, 1988. View at Google Scholar · View at Scopus
  15. M. J. Yin, Y. Yamamoto, and R. B. Gaynor, “The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β,” Nature, vol. 396, no. 6706, pp. 77–80, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Ghiselli, O. Laurenti, G. De Mattia, G. Maiani, and A. Ferro-Luzzi, “Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients,” Free Radical Biology and Medicine, vol. 13, no. 6, pp. 621–626, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. S. R. Powell, “Salicylate trapping of ·OH as a tool for studying post-ischemic oxidative injury in the isolated rat heart,” Free Radical Research, vol. 21, no. 6, pp. 355–370, 1994. View at Google Scholar · View at Scopus
  18. O. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of biological chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  19. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Google Scholar · View at Scopus
  20. R. L. Levine, J. A. Williams, E. R. Stadtman, and E. Shacter, “Carbonyl assays for determination of oxidatively modified proteins,” Methods in Enzymology, vol. 233, pp. 346–357, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. R. J. Reiter, D. X. Tan, R. M. Sainz, J. C. Mayo, and S. Lopez-Burillo, “Melatonin: reducing the toxicity and increasing the efficacy of drugs,” Journal of Pharmacy and Pharmacology, vol. 54, no. 10, pp. 1299–1321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Cuzzocrea, E. Mazzon, L. Dugo et al., “A role for superoxide in gentamicin-mediated nephropathy in rats,” European Journal of Pharmacology, vol. 450, no. 1, pp. 67–76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. T. Baltazar, R. J. Dinis-Oliveira, J. A. Duarte, M. L. Bastos, and F. Carvalho, “Antioxidant properties and associated mechanisms of salicylates,” Current Medicinal Chemistry, vol. 18, no. 21, pp. 3252–3264, 2011. View at Publisher · View at Google Scholar
  24. A. Colantoni, N. De Maria, P. Caraceni, M. Bernardi, R. A. Floyd, and D. H. Van Thiel, “Prevention of reoxygenation injury by sodium salicylate in isolated-perfused rat liver,” Free Radical Biology and Medicine, vol. 25, no. 1, pp. 87–94, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. S. H. Sha and J. Schacht, “Salicylate attenuates gentamicin-induced ototoxicity,” Laboratory Investigation, vol. 79, no. 7, pp. 807–813, 1999. View at Google Scholar · View at Scopus
  26. N. Stojiljkovic, D. Mihailovic, S. Veljkovic, M. Stoiljkovic, and I. Jovanovic, “Glomerular basement membrane alterations induced by gentamicin administration in rats,” Experimental and Toxicologic Pathology, vol. 60, no. 1, pp. 69–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. K. Hughes, P. K. Stricklett, E. Padilla, and D. E. Kohan, “Effect of reactive oxygen species on endothelin-1 production by human mesangial cells,” Kidney International, vol. 49, no. 1, pp. 181–189, 1996. View at Google Scholar · View at Scopus
  28. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. W. W. Tang, L. Feng, J. C. Mathison, and C. B. Wilson, “Cytokine expression, upregulation of intercellular adhesion molecule-1, and leukocyte infiltration in experimental tubulointerstitial nephritis,” Laboratory Investigation, vol. 70, no. 5, pp. 631–638, 1994. View at Google Scholar · View at Scopus
  30. V. Tugcu, E. Ozbek, A. I. Tasci et al., “Selective nuclear factor κ-B inhibitors, pyrolidium dithiocarbamate and sulfasalazine, prevent the nephrotoxicity induced by gentamicin,” BJU International, vol. 98, no. 3, pp. 680–686, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. R. A. Volpini, A. P. C. Balbi, R. S. Costa, and T. M. Coimbra, “Increased expression of p38 mitogen-activated protein kinase is related to the acute renal lesions induced by gentamicin,” Brazilian Journal of Medical and Biological Research, vol. 39, no. 6, pp. 817–823, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. E. N. Wardle, “Nuclear factor κB for the nephrologist,” Nephrology Dialysis Transplantation, vol. 16, no. 9, pp. 1764–1768, 2001. View at Google Scholar · View at Scopus
  33. N. Li and M. Karin, “Is NF-κB the sensor of oxidative stress?” FASEB Journal, vol. 13, no. 10, pp. 1137–1143, 1999. View at Google Scholar · View at Scopus
  34. E. Kopp and S. Ghosh, “Inhibition of NF-κB by sodium salicylate and aspirin,” Science, vol. 265, no. 5174, pp. 956–959, 1994. View at Google Scholar · View at Scopus
  35. F. Petronilho, L. Constantino, B. De Souza et al., “Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats,” Nephrology Dialysis Transplantation, vol. 24, no. 7, pp. 2077–2082, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Kaur and B. Halliwell, “Detection of hydroxyl radicals by aromatic hydroxylation,” Methods in Enzymology, vol. 233, pp. 67–82, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. K. V. Kumar, A. A. Shifow, M. U. R. Naidu, and K. S. Ratnakar, “Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats,” Life Sciences, vol. 66, no. 26, pp. 2603–2611, 2000. View at Google Scholar · View at Scopus
  38. N. Stojiljkovic, S. Veljkovic, D. Mihailovic et al., “Protective effects of pentoxifylline treatment on gentamicin-induced nephrotoxicity in rats,” Renal Failure, vol. 31, no. 1, pp. 54–61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. J. Kettle and C. C. Winterbourn, “Myeloperoxidase: a key regulator of neutrophil oxidant product,” Redox Report, vol. 3, no. 1, pp. 3–15, 1997. View at Google Scholar · View at Scopus
  40. R. J. Reiter, D. X. Tan, C. Osuna, and E. Gitto, “Actions of melatonin in the reduction of oxidative stress: a review,” Journal of Biomedical Science, vol. 7, no. 6, pp. 444–458, 2000. View at Google Scholar · View at Scopus
  41. K. K. Donnahoo, X. Meng, A. Ayala, M. P. Cain, A. H. Harken, and D. R. Meldrum, “Early kidney TNF-α expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion,” American Journal of Physiology, vol. 277, no. 3, pp. R922–R929, 1999. View at Google Scholar · View at Scopus
  42. J. Anrather, G. Racchumi, and C. Iadecola, “NF-κB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox,” Journal of Biological Chemistry, vol. 281, no. 9, pp. 5657–5667, 2006. View at Publisher · View at Google Scholar · View at Scopus